BACKGROUND AND PURPOSE: Prenatal drug exposure may influence the developing brain. Our aim was to study WM characteristics with DTI in children with prenatal opiate and polysubstance exposure and in controls. We assessed whether group differences in FA, DA, and DR could be found and related to cognitive function. MATERIALS AND METHODS: The study was approved by a committee for medical research ethics. Parents signed an informed consent; children gave spoken consent. Our sample included 14 prenatally substance-exposed adopted children (5 girls; age range, 8.6-13.9 years; mean, 11.3 +/- 1.7 years) and 14 control children (7 girls; age range, 9.0-10.2 years; mean, 9.8 +/- 0.3 years). Tract-based spatial statistics were used to define a common WM skeleton for the sample, and FA was compared between groups throughout the skeleton, controlling for age and sex. Clusters of significant group differences >or=100 voxels (P <. 05) were identified. FA, DA, and DR within clusters were correlated with cognitive function. RESULTS: Ten clusters of FA group differences, mostly in central, posterior, and inferior parts of the brain, were identified (P <. 05), showing lower FA in substance-exposed children. FA and DA correlated positively and DR, negatively with cognitive function across groups. CONCLUSIONS: Prenatally substance-exposed children exhibited lower FA in restricted areas of WM, mostly relatively central, inferior, and posterior, where myelination occurs early in development. Myelin in these areas may be particularly vulnerable to prenatal substance exposure. FA and DR related moderately to cognitive function. Potential confounding factors existed and were considered.
BACKGROUND AND PURPOSE: Prenatal drug exposure may influence the developing brain. Our aim was to study WM characteristics with DTI in children with prenatal opiate and polysubstance exposure and in controls. We assessed whether group differences in FA, DA, and DR could be found and related to cognitive function. MATERIALS AND METHODS: The study was approved by a committee for medical research ethics. Parents signed an informed consent; children gave spoken consent. Our sample included 14 prenatally substance-exposed adopted children (5 girls; age range, 8.6-13.9 years; mean, 11.3 +/- 1.7 years) and 14 control children (7 girls; age range, 9.0-10.2 years; mean, 9.8 +/- 0.3 years). Tract-based spatial statistics were used to define a common WM skeleton for the sample, and FA was compared between groups throughout the skeleton, controlling for age and sex. Clusters of significant group differences >or=100 voxels (P <. 05) were identified. FA, DA, and DR within clusters were correlated with cognitive function. RESULTS: Ten clusters of FA group differences, mostly in central, posterior, and inferior parts of the brain, were identified (P <. 05), showing lower FA in substance-exposed children. FA and DA correlated positively and DR, negatively with cognitive function across groups. CONCLUSIONS: Prenatally substance-exposed children exhibited lower FA in restricted areas of WM, mostly relatively central, inferior, and posterior, where myelination occurs early in development. Myelin in these areas may be particularly vulnerable to prenatal substance exposure. FA and DR related moderately to cognitive function. Potential confounding factors existed and were considered.
Authors: Jeffrey R Wozniak; Bryon A Mueller; Pi-Nian Chang; Ryan L Muetzel; Lydia Caros; Kelvin O Lim Journal: Alcohol Clin Exp Res Date: 2006-10 Impact factor: 3.455
Authors: Henrietta S Bada; Abhik Das; Charles R Bauer; Seetha Shankaran; Barry M Lester; Charlotte C Gard; Linda L Wright; Linda Lagasse; Rosemary Higgins Journal: J Perinatol Date: 2005-10 Impact factor: 2.521
Authors: Andu Turken; Susan Whitfield-Gabrieli; Roland Bammer; Juliana V Baldo; Nina F Dronkers; John D E Gabrieli Journal: Neuroimage Date: 2008-04-11 Impact factor: 6.556
Authors: Kristine B Walhovd; Christian K Tamnes; Ylba Østby; Paulina Due-Tønnessen; Anders M Fjell Journal: Eur Child Adolesc Psychiatry Date: 2012-02-01 Impact factor: 4.785
Authors: Andrew C Eschenroeder; Allison A Vestal-Laborde; Emilse S Sanchez; Susan E Robinson; Carmen Sato-Bigbee Journal: Glia Date: 2011-10-14 Impact factor: 7.452
Authors: Anders M Fjell; Kristine Beate Walhovd; Timothy T Brown; Joshua M Kuperman; Yoonho Chung; Donald J Hagler; Vijay Venkatraman; J Cooper Roddey; Matthew Erhart; Connor McCabe; Natacha Akshoomoff; David G Amaral; Cinnamon S Bloss; Ondrej Libiger; Burcu F Darst; Nicholas J Schork; B J Casey; Linda Chang; Thomas M Ernst; Jeffrey R Gruen; Walter E Kaufmann; Tal Kenet; Jean Frazier; Sarah S Murray; Elizabeth R Sowell; Peter van Zijl; Stewart Mostofsky; Terry L Jernigan; Anders M Dale Journal: Proc Natl Acad Sci U S A Date: 2012-11-12 Impact factor: 11.205
Authors: Kristen P Morie; Sarah W Yip; Zu Wei Zhai; Jiansong Xu; Kristen R Hamilton; Rajita Sinha; Linda C Mayes; Marc N Potenza Journal: Drug Alcohol Depend Date: 2017-02-28 Impact factor: 4.492
Authors: Annerine Roos; Maja A Kwiatkowski; Jean-Paul Fouche; Katherine L Narr; Kevin G F Thomas; Dan J Stein; Kirsty A Donald Journal: Behav Brain Res Date: 2014-11-12 Impact factor: 3.332
Authors: Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard Journal: Pediatrics Date: 2017-06 Impact factor: 7.124